Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

169 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-02

Study Completion Date

2026-01-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This early phase I trial studies potential differences between men and women when switching from the use of combustible cigarettes to the National Institute on Drug Abuse's Standard Research E-Cigarette (SREC). Studying the differences between men and women may increase understanding about the effects of switching from smoking regular cigarettes to electronic cigarettes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Gender Differences in Response to Nicotine Replacement Therapy and De-Nicotinized Cigarettes

NCT00960778

Nicotine Dependence

COMPLETED PHASE2

Examining the Effectiveness of the Nicotine Patch in Male and Female Smokers - 2

NCT00135746

Tobacco Use Disorder

COMPLETED NA

Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3

NCT00390559

Drug Addiction Smoking Cessation

COMPLETED NA

Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1

NCT00218140

Smoking Cessation Tobacco Use Disorder

COMPLETED PHASE2

Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users

NCT04003805

Smoking, Cigarette

ACTIVE_NOT_RECRUITING PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. To characterize the effects of switching to nicotine versus (vs.) placebo standard research E-cigarettes (SRECs) from combustible cigarettes (CCs) on product use, product acceptability, reinforcement, and nicotine dependence symptoms among adult daily CC smokers.

II. To characterize the differences between male and female CC smokers when switching to nicotine versus (vs.) placebo SRECs from CCs on product use, product acceptability, reinforcement, and nicotine dependence symptoms.

EXPLORATORY OBJECTIVE:

I. To characterize which factors moderate or mediate the effects of switching to nicotine and placebo SRECs from CCs among male and female CC smokers.

OUTLINE:

Participants will be instructed to smoke their usual brand cigarette as they normally would in weeks 1-2 (Phase I) and to use only the SREC (with or without nicotine) in weeks 3-4 (Phase II) and in weeks 5-6 (Phase III). Participant assignment to SREC type at Phases II and III will be counter-balanced within group, with half of men and women receiving the placebo SREC during Phase II and half during Phase III. Participants will attend 4 laboratory visits with study investigators for 3 hours each over 6 weeks of study participation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cigarette Smoking-Related Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

E-Cig placebo dose followed by E-Cig nicotine dose

Participants will be instructed to smoke their usual brand cigarette as they normally would in weeks 1-2 (Phase I) and to use only the SREC (with or without nicotine) in weeks 3-4 (Phase II) and in weeks 5-6 (Phase III). Participant assignment to SREC type at Phases II and III will be counter-balanced within group, with half of men and women receiving the placebo SREC during Phase II and half during Phase III. Participants will attend 4 laboratory visits with study investigators for 3 hours each over 6 weeks of study participation.

Group Type EXPERIMENTAL

Nicotine Replacement

Intervention Type DRUG

Received NRT (Electronic Cigarette - With Nicotine)

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Electronic Cigarette

Intervention Type DEVICE

Electronic Cigarette - with Nicotine

Electronic Cigarette

Intervention Type DEVICE

Electronic Cigarette -without Nicotine

E-Cig nicotine dose followed by E-Cig placebo dose

Participants will be instructed to smoke their usual brand cigarette as they normally would in weeks 1-2 (Phase I) and to use only the SREC (with or without nicotine) in weeks 3-4 (Phase II) and in weeks 5-6 (Phase III). Participant assignment to SREC type at Phases II and III will be counter-balanced within group, with half of men and women receiving the placebo SREC during Phase II and half during Phase III. Participants will attend 4 laboratory visits with study investigators for 3 hours each over 6 weeks of study participation.

Group Type EXPERIMENTAL

Nicotine Replacement

Intervention Type DRUG

Received NRT (Electronic Cigarette - With Nicotine)

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Electronic Cigarette

Intervention Type DEVICE

Electronic Cigarette - with Nicotine

Electronic Cigarette

Intervention Type DEVICE

Electronic Cigarette -without Nicotine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nicotine Replacement

Received NRT (Electronic Cigarette - With Nicotine)

Intervention Type DRUG

Questionnaire Administration

Ancillary studies

Intervention Type OTHER

Electronic Cigarette

Electronic Cigarette - with Nicotine

Intervention Type DEVICE

Electronic Cigarette

Electronic Cigarette -without Nicotine

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Nicotine Replacement Therapy NRT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 21 years or older
* Reports being a daily or non-daily smoker (any self-reported smoking in the past 30 days)
* Have an address where he/she can receive mail
* Able to follow verbal and written instructions in English and complete all aspects of the study as determined by PI
* Willing to have urine biospecimen samples taken, either in-home and returning them by mail, or in-person at an approved collection site.
* Willing to use tobacco-flavored study electronic cigarettes
* Agrees to comply with all MD Anderson institutional policies related to COVID-19 screening prior to any in-person research visit.
* The individual agrees to not engage in study procedures or interactions with study personnel while operating a vehicle.

Exclusion Criteria

* Individuals who report depressive symptoms in the moderately severe or severe range on the PHQ-9 (scores of 15 or above) or who report current suicidal ideation on the PHQ-9
* Uncontrolled or unstable medical condition (e.g., uncontrolled hypertension, angina, diabetes).
* Evidence of cognitive deficits or instability that would preclude reliable study participation.
* Being pregnant, engaging in breast-feeding, or being of childbearing potential and engaging in sexual activity that could lead to pregnancy and is not protected by a medically acceptable, effective method of birth control while enrolled in the study, as determined by self-report. Medically acceptable contraceptives include: (1) approved hormonal contraceptives (such as birth control pills, patches, implants or injections), (2) barrier methods (such as a condom or diaphragm) used with a spermicide, or (3) an intrauterine device (IUD). Contraceptive measures sold for emergency use after unprotected sex are not acceptable methods for routine use.
* Considered by the investigator to be an unsuitable or unstable candidate (including but not limited to the following situation: unwilling or unable to comply with study procedures)
* Individuals who reside in an area that is outside of our shipping company's area of operation or in a jurisdiction outside of our medical staff's licensure (if unable to attend in-person clinic visits) AND who decline or are unable to come in to clinic to provide necessary samples and/or collect study products.

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes